A quantitative-trait analysis of human plasma-dopamine β-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus

American Journal of Human Genetics

Volumn 68, Issue 2, 2001, Pages 515-522

  Zabetian, Cyrus P ^a,d   Anderson, George M ^b   Buxbaum, Sarah G ^e   Elston, Robert C ^e   Ichinose, Hiroshi ^f   Nagatsu, Toshiharu ^f   Kim, Kwang Soo ^g   Kim, Chun Hyung ^g   Malison, Robert T ^a,c   Gelernter, Joel ^a,d   Cubells, Joseph F ^a,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yale University School of Medicine   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f FUJITA HEALTH UNIVERSITY   (Japan)

^g MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; GENE PRODUCT; PROTEIN DBH; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ENZYME ACTIVITY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE TRAIT; STRUCTURAL GENE;

EID: 0035125773     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/318198     Document Type: Article

References (47)

1. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenics
2. An analysis of transformations
3. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34
4. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH)
5. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia
6. Dopamine beta-hydroxylase: Two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation
7. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT
8. Human serum dopamine beta-hydroxylase: Correlation of enzymatic activity with immunoreactive protein in genetically defined samples
9. Segregation and linkage analyses of dopamine-beta-hydroxylase activity
10. Longitudinal assessment of MAO-, COMT-, and DBH- activity in patients with bipolar depression
11. Serum dopaminebeta-hydroxylase in schizophrenic patients
12. Sequence tagged site (STS) TaqI RFLP at dopamine beta-hydroxylase (DBH)
13. Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): Possible linkage between the ABO locus and a gene controlling DBH activity
14. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis
15. Cell-specific expression from the human dopamine beta-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements
16. Neuron-specific expression of the human dopamine beta-hydroxylase gene requires both the cAMP-response element and a silencer region
17. Immunocytochemical localization of dopamine-beta-hydroxylase in neurons of the human brain stem
18. Noradrenergic-specific transcription of the dopamine beta-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites
19. Human dopamine beta-hydroxylase gene: Two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation
20. The primary structure of human dopamine-beta-hydroxylase: Insights into the relationship between the soluble and the membrane-bound forms of the enzyme
21. Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease
22. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease: A retrospective comparison
23. Depression, antidepressants, and plasma DBH
24. Plasma dopamine-beta-hydroxylase in depressed patients
25. Serum dopamine-beta-hydroxylase activity in schizophrenia
26. Dopamine-beta-hydroxylase activity in cerebrospinal fluid of Parkinsonian patients
27. Distribution of dopamine-β-hydroxylase in subcellular fractions of adrenal medulla
28. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - A genetic study
29. Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man
30. Linkage analysis of the human dopamine beta-hydroxylase gene
31. Searching for genetic determinants in the new millennium
32. Genetic control of plasma dopamine-β-hydroxylase
33. Serum noradrenaline response to standing up in patients with Parkinson's disease
34. Release of catecholamines and dopamine-β-hydroxylase from the adrenal medulla
35. Neuropathology of autonomic nervous system in Parkinson's disease
36. n repeat at its gene locus in healthy individuals
37. Serum dopamine β-hydroxylase
38. Biochemical genetics of catecholamines in humans
39. Serum dopamine-beta-hydroxylase activity
40. Reduced plasma dopamine-beta-hydroxylase activity in familial dysautonomia
41. Serum dopamine-beta-hydroxylase activity: Sibling-sibling correlation
42. Inheritance of very low serum dopamine-beta-hydroxylase activity
43. Stepwise oligogenic segregation and linkage analysis illustrated with dopamine-β-hydroxylase activity
44. Linkage of a gene regulating dopamine-β-hydroxylase activity and the ABO blood group locus
45. Effect of cold pressor stimulation on plasma norepinephrine, dopamine-β-hydroxylase, and renin activity
46. Functional variants at CYP2A6: New genotyping methods, population genetics, and relevance to studies of tobacco dependence